Brittni Usera, MD
Radiation Oncology · Carson City, NVNPI 1497259337
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 11.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $811, 2.4 times the $338 reported in 2023.
Across 41 payments — averaging $32.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elekta, Inc.$151
- Accuray Incorporated$132
- Brainlab, Inc.$123
- Novocure Inc.$96
- Johnson & Johnson$95
- Merck$88
- plus $633 from 21 others
What the payments were for
- Food & beverage$1,318100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elekta, Inc. | 1 | $151 |
| Accuray Incorporated | 1 | $132 |
| Brainlab, Inc. | 1 | $123 |
| Novocure Inc. | 3 | $96 |
| Johnson & Johnson | 4 | $95 |
| Merck | 3 | $88 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Sobi, Inc | 2 | $50 |
| Tersera Therapeutics LLC | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Astellas Pharma US Inc | 2 | $39 |
| Ipsen Biopharmaceuticals, Inc | 2 | $38 |
| AstraZeneca | 2 | $37 |
| Gilead | 1 | $35 |
| Kyowa Kirin, Inc. | 1 | $29 |
| Sanofi | 1 | $28 |
| Coherus Oncology, Inc. | 1 | $27 |
| Incyte Corporation | 1 | $25 |
| Tactile Systems Technology Inc | 1 | $25 |
| Puma Biotechnology, Inc. | 1 | $24 |
| Eisai Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Blueprint Medicines Corporation | 1 | $19 |
| AbbVie | 1 | $16 |
| EMD Serono, Inc. | 1 | $16 |
| Apellis Pharmaceuticals, Inc. | 1 | $15 |
| Bayer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,318 in reported general payments places this provider in the 60th percentile of 47 radiation oncology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $223 |
| Tamsulosin Hcl | 12 | $195 |
| Memantine Hcl ErMemantine Hcl | 16 | $188 |
| Oxycodone Hcl | 14 | $141 |
| Lorazepam | 11 | $49 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Carson City
- Beth HummerCarson City$71
- Matthew SchwartzHenderson$169K
- Guy JonesReno$57K
- Garrett GreenReno$37K
- Michael AndersonHenderson$36K
- Jason KehrerReno$27K
- Farzaneh FarzinLas Vegas$12K
- Samual FrancisLas Vegas$10K
- Ritchie StevensLas Vegas$9K
- Anita PomerantzLas Vegas$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.